Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Total Non-Current Liabilities (2020 - 2025)

Precision Biosciences (DTIL) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $72.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 7.07% to $72.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $72.8 million, a 7.07% decrease, with the full-year FY2024 number at $77.2 million, down 45.17% from a year prior.
  • Total Non-Current Liabilities was $72.8 million for Q3 2025 at Precision Biosciences, down from $74.7 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $203.1 million in Q1 2021 to a low of $65.1 million in Q1 2025.
  • A 5-year average of $123.9 million and a median of $119.6 million in 2021 define the central range for Total Non-Current Liabilities.
  • Peak YoY movement for Total Non-Current Liabilities: soared 61.66% in 2022, then tumbled 52.69% in 2025.
  • Precision Biosciences' Total Non-Current Liabilities stood at $110.3 million in 2021, then skyrocketed by 52.03% to $167.7 million in 2022, then fell by 16.06% to $140.8 million in 2023, then tumbled by 45.17% to $77.2 million in 2024, then decreased by 5.63% to $72.8 million in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Total Non-Current Liabilities are $72.8 million (Q3 2025), $74.7 million (Q2 2025), and $65.1 million (Q1 2025).